Suzhou Connect Biopharmaceuticals, Ltd.
HomeحContact UsحSite Map
Connect Biopharma focuses on bringing novel and innovative medicines to commercialization in China. We plan to advance our drug candidates through clinical studies and obtain market approval in China. We plan to out-license the development and commercialization rights outside China of our clinical-stage assets. We are interested in:
 Partnership or In-licensing opportunities of preclinical programs and drug candidates that have the potential to be best-in-class or first-in-class.
 Strategic partnership or out-licensing opportunities of our clinical programs for commercialization rights outside China.
Please contact us if you are interested in these opportunities.
Copyright: Suzhou Connect Biopharmaceuticals, Ltd.